Outcomes
|
First author
|
Year
|
Types
|
AMSTAR 2
|
GRADE
|
---|
Mortality
| | | | | |
All-cause mortality
|
Mazidi
|
2018
|
Milk
|
Moderate
|
Low
|
CHD mortality
|
Mazidi
|
2018
|
Milk
|
Moderate
|
Low
|
All cancer mortality
|
Lu
|
2016
|
Milk
|
High
|
Low
|
Prostate cancer mortality
|
Lu
|
2016
|
Milk
|
High
|
Very low
|
Prostate cancer mortality
|
Lu
|
2016
|
Skim/low-fat milk
|
High
|
Very low
|
Cancer
| | | | | |
CRC
|
Barrubes
|
2019
|
Milk
|
Low
|
Moderate
|
CRC
|
Barrubes
|
2019
|
Low-fat milk
|
Low
|
Low
|
Prostate cancer
|
Aune
|
2015
|
Milk
|
Low
|
Moderate
|
DLBCL
|
Wang
|
2016
|
Milk
|
Critically low
|
Low
|
Gastric cancr
|
Wang
|
2018
|
Milk
|
Critically low
|
Moderate
|
Bladder Cancer
|
Bermejo
|
2019
|
Milk
|
Moderate
|
Moderate
|
Bladder Cancer
|
Bermejo
|
2019
|
Whole milk
|
Moderate
|
Low
|
Breast cancer
|
Chen
|
2019
|
Low-fat milk
|
Critically low
|
Very low
|
Breast cancer
|
Chen
|
2019
|
Milk
|
Critically low
|
Low
|
Breast cancer
|
Wu
|
2016
|
Milk
|
Moderate
|
Moderate
|
Breast cancer
|
Wu
|
2016
|
Skim milk
|
Moderate
|
Moderate
|
Endometrial cancer
|
Li
|
2017
|
Milk
|
Moderate
|
Moderate
|
ESCC
|
Li
|
2016
|
Milk
|
High
|
Moderate
|
FL
|
Wang
|
2016
|
Milk
|
Critically low
|
Very low
|
HCC
|
Yang
|
2017
|
Milk
|
Low
|
Moderate
|
Lung cancer
|
Yang
|
2016
|
Milk
|
Moderate
|
Moderate
|
Lung cancer
|
Yang
|
2016
|
Low-fat milk
|
Moderate
|
Low
|
NHL
|
Sergentanis
|
2019
|
Milk
|
Low
|
Low
|
Ovarian cancer
|
Liu
|
2015
|
Low-fat/skim milk
|
Critically low
|
Low
|
Ovarian cancer
|
Liu
|
2015
|
Milk
|
Critically low
|
Moderate
|
Pancreatic cancer
|
Genkinger
|
2014
|
Milk
|
Critically low
|
Moderate
|
Pancreatic cancer
|
Genkinger
|
2014
|
Whole milk
|
Critically low
|
Moderate
|
Pancreatic cancer
|
Genkinger
|
2014
|
Low-fat milk
|
Critically low
|
Moderate
|
SLL/CLL
|
Wang
|
2016
|
Milk
|
Critically low
|
Very low
|
Cardiovascular outcomes
| | | | | |
CVD
|
Guo
|
2017
|
Milk
|
High
|
Low
|
CVD
|
Soedamah-Muthu
|
2011
|
Milk
|
Low
|
Low
|
CHD
|
Gholami
|
2017
|
Milk
|
Moderate
|
Moderate
|
Arterial Stiffness
|
Diez-Fernandez
|
2019
|
Milk
|
High
|
Moderate
|
Hypertension
|
Soedamah-Muthu
|
2012
|
Milk
|
Low
|
Moderate
|
Stroke
|
de Goede
|
2016
|
Milk
|
Moderate
|
Moderate
|
Stroke
|
de Goede
|
2016
|
High-fat milk
|
Moderate
|
Low
|
Stroke
|
de Goede
|
2016
|
Low-fat milk
|
Moderate
|
Low
|
Stroke
|
Gholami
|
2017
|
Milk
|
Moderate
|
Moderate
|
Metabolic outcomes
| | | | | |
Abdominal obesity
|
Lee
|
2018
|
Milk
|
Moderate
|
Moderate
|
T2DM
|
Gijsbers
|
2016
|
Milk
|
Moderate
|
Low
|
T2DM
|
Gijsbers
|
2016
|
Low-fat milk
|
Moderate
|
Low
|
T2DM
|
Gijsbers
|
2016
|
High-fat milk
|
Moderate
|
Low
|
Hypertriacylglycerolaemia
|
Lee
|
2018
|
Milk
|
Moderate
|
Low
|
Metabolic Syndrome
|
Mena
|
2019
|
Milk
|
Critically low
|
Moderate
|
Metabolic Syndrome
|
Lee
|
2018
|
Milk
|
Moderate
|
Moderate
|
Obesity
|
Wang
|
2016
|
Milk
|
Low
|
Moderate
|
T2DM
|
Tian
|
2017
|
Whole milk
|
Low
|
Low
|
Skeletal outcomes
| | | | | |
Hip fracture
|
Malmir
|
2019
|
Milk
|
Low
|
Low
|
Osteoporosis
|
Malmir
|
2019
|
Milk
|
Low
|
Moderate
|
Vertebral fracture
|
Matia
|
2019
|
Milk
|
Low
|
Very low
|
Neurological outcomes
| | | | | |
Alzheimer's disease
|
Wu
|
2016
|
Milk
|
Moderate
|
Very low
|
Cognitive Disorders
|
Wu
|
2016
|
Milk
|
Moderate
|
Low
|
Cognitive function
|
Lee
|
2018
|
Milk
|
Moderate
|
Very low
|
Parkinson’s disease
|
Jiang
|
2014
|
Milk
|
Low
|
Low
|
Dementia
|
Wu
|
2016
|
Milk
|
Moderate
|
Very low
|
Infant outcomes
| | | | | |
FDA
|
Griebler
|
2016
|
Milk
|
Low
|
Low
|
T1DM
|
Griebler
|
2016
|
Milk
|
Low
|
Low
|
Other outcomes
| | | | | |
Acne
|
Aghasi
|
2019
|
Milk
|
Low
|
Moderate
|
Dental erosion
|
Li
|
2012
|
Milk
|
Critically low
|
Very low
|
Endometriosis
|
Hoorsan
|
2017
|
Milk
|
Low
|
Very low
|
- AMSTAR a measurement tool to assess systematic reviews, GRADE Grading of Recommendations Assessment, Development, and Evaluation, CVD cardiovascular disease, CHD coronary heart disease, CRC colorectal cancer, DLBCL diffuse large B-cell lymphoma, ESCC esophageal squamous cell carcinoma, FL follicular lymphoma, HCC hepatocellular carcinoma, NHL non-Hodgkin’s lymphoma, SLL/CLL small lymphocytic lymphoma/chronic lymphocytic leukemia, T2DM type 2 diabetes mellitus, FDA Fe-deficiency anaemia, T1DM type 1 diabetes mellitus